Stock Events

Stock Events

Atlas Energy

0

0

+$0.00+0% 00:00 Today

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Upcoming

Earnings

Nov 17Expected

Q3 2022

Q2 2026

Next

-0.11

0.22

0.56

0.89

Expected EPS

N/A

Actual EPS

N/A

Financials

-Profit Margin

Unprofitable

2020

2021

2022

2023

2024

2025

0Revenue

-989,000.03Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AEEYY. It's not an investment recommendation.

Toronto Dominion Bank

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

CRISPR Therapeutics

CRISPR Therapeutics is involved in gene editing, a technology that can be seen as complementary or competitive to biosynthesis in developing therapeutic products.

Editas Medicine

Editas Medicine operates in the genome editing field, which competes with biosynthesis for applications in medicine and agriculture.

Intellia Therapeutics

Intellia Therapeutics is another key player in the CRISPR space, potentially competing with Willow in the development of novel therapeutics.

Evogene utilizes computational biology to improve product development in agriculture, which could compete with Willow's biosynthetic approaches in the same sector.

Synlogic operates in synthetic biology, using engineered bacteria for therapeutic purposes, which is a direct competitor to Willow's biosynthesis technologies.

Adaptive Biotechnologies

Adaptive Biotechnologies focuses on the immune-driven discovery and development of therapeutics, potentially competing in the biotech space with Willow.

Twist Bioscience

Twist Bioscience specializes in synthetic DNA production, which is foundational for biosynthesis and directly competes with Willow's technology platform.

Co-Diagnostics uses molecular diagnostics for detection of DNA or RNA, which can be seen as a competing technology for applications targeted by Willow's biosynthesis.

Pacific Biosciences of California

Pacific Biosciences offers sequencing technologies that, while not directly competitive, are part of the broader biotech ecosystem that intersects with Willow's market.

About

Founded in 1981 and headquartered in Calgary, Canada, Willow Biosciences Inc. operates as a biotechnology enterprise. The company is dedicated to the creation, manufacturing, and distribution of plant-derived compounds, primarily serving the consumer care, food and beverage, and pharmaceutical industries across Canada. A core part of its product portfolio includes cannabidiol (CBD), cannabigerol (CBG), and various varin cannabinoids, such as cannabigerovarin (CBGV), cannabidivarin (CBDV), and tetrahydrocannabivarin (THCV).

Show More

CEO

Travis Doupe

Employees

19

Country

Canada

ISIN

US0489244014

Listings

0 Comments

Share your thoughts

FAQs

What is Atlas Energy stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Atlas Energy stocks are traded under the ticker AEEYY.

When is the next Atlas Energy earnings date?▼

Atlas Energy is going to release the next earnings report on November 17, 2026.

What is Atlas Energy revenue for the last year?▼

Atlas Energy revenue for the last year amounts to 0 USD.

What is Atlas Energy net income for the last year?▼

AEEYY net income for the last year is -989,000.03 USD.

How many employees does Atlas Energy have?▼

As of November 7, 2026, the company has 19 employees.

In which sector is Atlas Energy located?▼

Atlas Energy operates in the Health & Wellness sector.

When did Atlas Energy complete a stock split?▼

The last stock split for Atlas Energy was on June 23, 2025 with a ratio of 1:5.

Where is Atlas Energy headquartered?▼

Atlas Energy is headquartered in Calgary, Canada.